Table 1.

Summary of Results for All Patients

Patient Number	Age	Sex	Observer Avg Max Depth of Filler (mm)	Max Thickness T2 Signal	Years post Treatment	Protocol
1	52	F	7.5	Moderate	>5	Standard full
2	56	F	7	Moderate	2–5	Standard full
3	61	F	10	Severe	2–5	Standard full
4	52	F	9	Moderate	2–5	Standard full
5	46	F	11	Severe	>5	Standard full
6	64	F	11	Severe	2–5	Standard full
7	53	F	3	Mild	>5	Standard full
8	37	F	6	Moderate	>5	Standard full
9	44	F	8.5	Moderate	>5	Trial (T2Fs ax/cor)
10	62	F	2.5	Mild	2–5	Standard full
11	52	F	9.5	Severe	2–5	Trial (T2Fs ax/cor)
12	30	F	4.5	Mild	2–5	Trial (T2Fs ax/cor)
13	33	F	5.5	Mod	2–5	Trial (T2Fs ax/cor)
14	32	F	3.5	Mild	2–5	Trial (T2Fs ax/cor)
15	32	F	5	Mild	2–5	Trial (T2Fs ax/cor)
16	43	F	9.5	Mod	2–5	Trial (T2Fs ax/cor)
17	50	M	4.5	Mild	2–5	Standard Full
18	63	F	15	Severe	>5	Standard full
19	46	F	8	Moderate	2–5	Standard full
20	36	F	10	Moderate	2–5	Standard full
21	50	F	19	Severe	2–5	Standard full
22	41	F	7	Moderate	2–5	Standard full
23	40	F	12	Severe	2–5	Standard full
24	36	F	9.5	Severe	2–5	Standard full
25	48	F	10.7	Severe	2–5	Trial (T2Fs ax/cor)
26	60	F	10	Moderate	>5	Standard full
27	56	F	7	Moderate	2–5	Trial (T2Fs ax/cor)
28	42	F	11.3	Severe	>5	Standard full
29	32	F	8.5	Moderate	>5	Trial (T2Fs ax/cor)
30	60	F	5.5	Mild	2–5	Trial (T2Fs ax/cor)
31	40	F	10	Severe	>5	Trial (T2Fs ax/cor)
32	69	F	7.5	Moderate	2–5	Standard full
33	52	F	7.5	Moderate	>5	Standard full